Ameris Bancorp is a financial holding company. Through its subsidiary, Ameris Bank, the company provides a range of banking services to its retail and commercial customers in Georgia, Alabama, Florida and South Carolina. The company provides agricultural loans, commercial business loans, commercial and residential real estate construction and mortgage loans, consumer loans, revolving lines of credit and letters of credit. The company also provides a range of deposit accounts and services to both retail and commercial customers, which include commercial and retail checking accounts, regular interest-bearing savings accounts, money market accounts, individual retirement accounts and certificates of deposit.

Anixa Biosciences is a biotechnology company focused on using the body's immune system to diagnose, treat and prevent cancer. The company's subsidiary, Anixa Diagnostics Corporation, develops Cchek?, a platform for non-invasive blood tests for the early detection of cancer. The company's subsidiary, Certainty Therapeutics, Inc., develops immuno-therapy drugs against cancer. The company has focused on the development of a treatment for ovarian cancer. The company is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.

Brickell Biotech is a clinical-stage pharmaceutical company focused on the development of prescription therapeutics for the treatment of debilitating skin diseases. The company's pipeline consists of therapeutics for hyperhidrosis and other prevalent dermatological conditions. The company's Sofpironium bromide is a topical anticholinergic product candidate, developed for once-daily treatment of primary axillary hyperhidrosis in adult and pediatric patients nine years of age and older. Sofpironium bromide was retrometabolically designed. Retrometabolic drugs are intended to exert their action topically and are metabolized once absorbed into the blood.